Gan & Lee Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Gan & Lee Pharmaceuticals has a total shareholder equity of CN¥11.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥12.2B and CN¥1.0B respectively. Gan & Lee Pharmaceuticals's EBIT is CN¥249.6M making its interest coverage ratio -2. It has cash and short-term investments of CN¥5.1B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -2x |
| Cash | CN¥5.07b |
| Equity | CN¥11.21b |
| Total liabilities | CN¥1.01b |
| Total assets | CN¥12.22b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603087's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥806.7M).
Long Term Liabilities: 603087's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥208.1M).
Debt to Equity History and Analysis
Debt Level: 603087 is debt free.
Reducing Debt: 603087 had no debt 5 years ago.
Debt Coverage: 603087 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 603087 has no debt, therefore coverage of interest payments is not a concern.